India IVF secures USD 1.25 mn investment from tomorrow capital

India IVF, a pioneering fertility provider founded by Dr Richika Sahay and Dr Somendra Shukla in 2014, has secured USD 1.25 million in pre-Series A funding from Tomorrow Capital, a USD 100 million venture capital fund dedicated to supporting early-stage, transformative consumer healthcare businesses.

- 

This investment represents India IVF's first external funding since its inception, following a decade of profitable operations across its five North Indian centers, which include clinics in Delhi NCR and Srinagar.

This new funding from Tomorrow Capital will drive India IVF's expansion across North India, enabling the company to bridge critical gaps in fertility care access.

With the goal of making advanced fertility solutions accessible to underserved communities, India IVF has established India's first tech-enabled fertility platform, offering comprehensive, 360-degree fertility care through advanced technology and a dedicated team of experts.

Tomorrow Capital's investment follows its recent support of VitusCare and IndiShreshtha, further reinforcing its commitment to specialized healthcare ventures.

Rahul Saha, Senior Principal at Tomorrow Capital, said, "India IVF has shown remarkable growth and a deep understanding of the unique fertility challenges faced by many Indian couples. With a tech-enabled, patient-focused approach, they deliver high-quality personalized care, addressing the often-emotional & stigma attached journey of the fertility treatment.

Tomorrow Capital backs ventures that drive meaningful impact, and with India IVF, we're proud to enable access to essential fertility care across underserved regions in India. We believe their innovative approach will set new standards in India's fertility sector, and we are excited to support their mission to make fertility care more accessible across the country."